Enzo Biochem, Inc. (MUN:EZB)

Market Cap	30.88M
Revenue (ttm)	24.22M
Net Income (ttm)	-18.58M
Shares Out	n/a
EPS (ttm)	-0.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6
Open	0.5900
Previous Close	0.5900
Day's Range	0.5900 - 0.5900
52-Week Range	0.4020 - 0.5950
Beta	n/a
RSI	73.99
Earnings Date	Oct 13, 2025

About Enzo Biochem

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, ge...

• Industry: Laboratory Analytical Instruments
• Founded: 1976
• Employees: 136
• Stock Exchange: Munich Stock Exchange
• Ticker Symbol: EZB

Financial Performance

Financial numbers in USD